Publication
  • ACR •
  • 28 October, 2025 •
  • •

Nanoencapsulated Sirolimus Plus Pegadricase (NASP) Demonstrates a Reduction in Gout Flares: Results From the Phase 3 DISSOLVE Studies

Angelo Gaffo, Herbert Baraf, Anand Patel, Tuhina Neogi, Rehan Azeem, Wesley DeHaan, Ben Peace, Hugues Santin-Janin, Bhavisha Desai, Naomi Schlesinger

Available materials

Oral Presentation
Publication
  • ACR •
  • 28 October, 2025 •
  • •

Economic Burden of Macrophage Activation Syndrome (MAS) in Patients with Still’s Disease (Systemic Juvenile Idiopathic Arthritis (sJIA) and Adult-onset Still’s Disease (AOSD): Analysis of a US National Administrative Claims Database

Michael Marrone, Christopher McPherson, Abiola Oladapo

Available materials

Poster
Publication
  • ACR •
  • 28 October, 2025 •
  • •

Nanoencapsulated Sirolimus Plus Pegadricase Reduced Disease Burden in Patients With Uncontrolled Gout: Results From the Phase 3 DISSOLVE Trials

Puja Khanna, Amar Majjhoo, Rehan Azeem, Ben Peace, Bhavisha Desai, Vibeke Strand

Available materials

Oral Presentation
Publication
  • ACR •
  • 28 October, 2025 •
  • •

Characterization of Infusion Reactions Within 1 Hour of Treatment With Nanoencapsulated Sirolimus Plus Pegadricase: Pooled Results From the Phase 3 DISSOLVE I and DISSOLVE II Trials

Herbert Baraf, Andrew Sulich, Guillermo Valenzuela, Rehan Azeem, Ben Peace, Bhavisha Desai, Herbert Baraf

Available materials

Poster
Publication
  • ISPOR •
  • 18 May, 2026 •
  • •

Association Between Clinical Manifestations of Gout and Patient Reported Outcome Measures: Results of a Real-World Survey in the United States

Andrew Sulich, Menaka Bhor, James Hawthorne, Emily Goddard, Molly Edwards, Alastair Hinds, Ted Mikuls

Available materials

Poster
Publication
  • NKF •
  • 7 May, 2026 •
  • •

Nanoencapsulated Sirolimus Plus Pegadricase (NASP) Provides a Sustained 48-Week Response, Reducing Serum Uric Acid and Preserving Renal Function in Patients With Uncontrolled Gout (UG) and Stage 3 Chronic Kidney Disease

Nissreen Elfadawy, Rehan Azeem, Pirooz Parsa, Ben Peace, Yasir A. Qazi

Available materials

Poster
Publication
  • NKF •
  • 7 May, 2026 •
  • •

Treatment Patterns and Clinical Outcomes in Patients with both Uncontrolled Gout and Chronic Kidney Disease

Samuel Piedad, Pirooz Parsa, Menaka Bhor, Molly Edwards, Emily Goddard, Saravanan Balamuthusamy

Available materials

Poster
Publication
  • CCR East •
  • 1 May, 2026 •
  • •

Comparison of Diagnostic Journey and Utilization of Clinical Care Resources in Uncontrolled vs. Controlled Gout in the United States

Jigar Shah, Menaka Bhor, James Hawthorne, Nathan Meyer, Emily Goddard, Molly Edwards, Alastair Hinds, John A. Albert

Available materials

Poster
Sign up for alerts